Rising Prevalence Of Hospital-acquired Infections Is Projected to Drive the Ultrasound Probe Disinfection Market's Demand

 

According to the World Health Organization, the prevalence of hospital-acquired infections (HAI's) in developed countries at any given time is between 3.5%-12%. These infections include nosocomial infection due to ultrasound probes, central line-associated bloodstream infections, hospital-acquired pneumonia, and clostridium difficile infections. With the increase in chronic and contagious disease cases, more and more people visit hospitals or any other healthcare facilities. Thus, the cases of hospital-acquired infections (HAI's) increase, which further escalates the demand for the disinfection process.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-ultrasound-probe-disinfection-market

Data Bridge Market Research analyses that the ultrasound probe disinfection market is expected to grow at a CAGR of 16.5% in the forecast period of 2021 to 2029 and is expected to reach USD 1,349.31 million by 2029. In developed and developing countries, the hospitals are using disinfection probes for testing purposes, and that's why they're increasing the use of high-level disinfection systems, which is expected to provide a great opportunity for the ultrasonic probe disinfection market.

 Global Ultrasound Probe Disinfection Market

Surge in Chronic and Contagious Diseases is anticipated to Propel Market Growth

The growing prevalence of chronic and contagious diseases leads to generating enormous demand for ultrasound procedures and disinfectants during the treatment. Contagious diseases spread in several ways from person to person. Chronic diseases generally occur in older adults that can be controlled but not cured, such as heart disease, arthritis, diabetes, stroke, or cancer. The ultrasound probe is used in various chronic diseases such as abdominal, cardiac, endovaginal (EV) obstetrics and gynecology procedures, transesophageal echocardiography, and endorectal (ER) prostate applications, among others. Therefore, the increased prevalence of chronic and contagious diseases is estimated to boost market growth.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 to 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Products and Services (Instruments, Consumables, Services), Level of Disinfection (Low Level Disinfection, Intermediate Level Disinfection, High Level Disinfection), Type of Probe (Critical Devices, Noncritical Devices, Semicritical Devices), End User (Hospitals and Diagnostic Imaging Centers, Ambulatory Care Centers, Maternity Centers, Academic and Research Institutes, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

General Electric (U.S.), Nanosonics (Australia), Tristel plc (UK), STERIS (U.S.), Ecolab (U.S.), ASP India Private Ltd. (U.S.), CIVCO Medical Solutions (U.S.), CS Medical, LLC (U.S.), Virox (Canada), Germitec (France), Schülke & Mayr GmbH (Germany), Parker Laboratories Inc. (U.S.), Metrex Research, LLC (U.S.), Dr. Schumacher GmbH (Germany), Whiteley AllCAre(New Zealand), MMM Group (Germany), GAMA Healthcare Ltd. (UK), Ruhof (U.S.), BODE Chemie GmbH (Germany), Advanced Ultrasound Solutions Inc. (U.S.) and IMA-X (Luxembourg).

Data Points Covered in Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The ultrasound probe disinfection market is segmented on the basis of products and services, level of disinfection, type of probe, end user and distribution channel.

  • On the basis of products and services, the global ultrasound probe disinfection market is segmented into instruments, consumables, and services. In 2022, the instruments segment is expected to dominate the global ultrasound probe disinfection market with a 59.7% market share due to the launch of various instruments in the market.
  • On the basis of the level of disinfection, the global ultrasound probe disinfection market is segmented into low level disinfection, intermediate level disinfection, and high level disinfection. The high level disinfection segment is expected to dominate the global ultrasound probe disinfection market with an 85.4% market share

The high level disinfection segment is expected to dominate the global ultrasound probe disinfection market.

In 2022, the high level disinfection segment is expected to dominate the global ultrasound probe disinfection market with an 85.4% market share as it provides the highest safety to the patient as well as medical staff without transmission of infection. These affirmative parameters are anticipated to propel the market growth in the forecast period.

  • On the basis of the type of probe, the global ultrasound probe disinfection market is segmented into critical devices, noncritical devices, and semi-critical devices. In 2022, the critical devices segment is expected to dominate the market with a 59.2% market share as the device requires a high level of disinfection.
  • On the basis of end user, the global ultrasound probe disinfection market is segmented into hospitals and diagnostic imaging centers, ambulatory care centers, maternity care centers, academic and research institutes, and others. The hospitals and diagnostic imaging centers segment is expected to dominate the global ultrasound probe disinfection market with a 48.9% market share.

The hospitals and diagnostic imaging centres segment is expected to dominate the global ultrasound probe disinfection market.

In 2022, the hospitals and diagnostic imaging centres segment is expected to dominate the global ultrasound probe disinfection market with a 48.9% market share. This is due to the increasing investment in the healthcare segment and rising measures to ensure the safety of workers and patients in hospitals, as hospital-acquired infections are increasing.

  • On the basis of distribution channel, the global ultrasound probe disinfection market is segmented into direct tender, third party distributors, and others. In 2022, the direct tender segment is expected to dominate the global ultrasound probe disinfection market with a 65.7% market share because consumers are aware of this distribution channel, and they prefer direct sales for seeking the benefits of discounts, bulk buying, and easy availability of products.

Major Players

Data Bridge Market Research recognizes the following companies as the major ultrasound probe disinfection market players in ultrasound probe disinfection market are General Electric (U.S.), Nanosonics (Australia), Tristel plc (UK), STERIS (U.S.), Ecolab (U.S.), ASP India Private Ltd. (U.S.), CIVCO Medical Solutions (U.S.), CS Medical, LLC (U.S.), Virox (Canada), Germitec (France), Schülke & Mayr GmbH (Germany), Parker Laboratories Inc. (U.S.), Metrex Research, LLC (U.S.), Dr. Schumacher GmbH (Germany), Whiteley AllCAre(New Zealand), MMM Group (Germany), GAMA Healthcare Ltd. (UK), Ruhof (U.S.), BODE Chemie GmbH (Germany), Advanced Ultrasound Solutions Inc. (U.S.) and IMA-X (Luxembourg).

 Global Ultrasound Probe Disinfection Market

  • In November 2021, Tristel plc announced that it had participated in the Annual Infection Control, Sterilization, and Decontamination in Healthcare Conference. This has helped the company to furnish correct knowledge about its products in the market.
  • In February 2019, Germitec announced the release of a new chemical-free, ultrafast high-level disinfection (HLD) system for ultrasound probes. UV-based HLD technology is used in the Hypernova Chronos system, which is designed for external, vaginal, and rectal ultrasound probes. In vitro and ex vivo, it is an effective disinfection system against human papillomavirus (HPV).

Regional Analysis

Geographically, the countries covered in the ultrasound probe disinfection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in ultrasound probe disinfection market during the forecast period

North America dominated the ultrasound probe disinfection market owing to the rise in epidemic and pandemic events and the presence of sophisticated healthcare infrastructure. North America will continue to dominate the ultrasound probe disinfection market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increasing demand for high-level disinfectants in this region. 

Asia-Pacific is estimated to be the fastest-growing region in ultrasound probe disinfection market

Asia-Pacific is expected to grow during the forecast period due to the major companies foraying into the market. China is expected to dominate in the region due to increasing prevalence of bacterial infection and introduction of latest technologies in the healthcare sectors.

COVID-19 Impact Analysis

The outbreak of COVID-19 largely impacted the healthcare industry. Frontline healthcare workers are at a much higher risk of developing severe acute respiratory syndrome coronavirus 2 because of the virus's high transmissibility (SARS-CoV-2). As a result of frequent direct contact with large numbers of patients, imaging equipment, particularly ultrasound, is at high risk for surface transmission. The number of ultrasound imaging procedures performed during COVID-19 was drastically reduced. During the peak of the COVID-19 pandemic, the ultrasound probe disinfection instruments market was negatively impacted, and this trend continued until December 2020. The market for consumables is expected to be impacted by the decline in the number of ultrasound imaging procedures.

However, the consumables market does not appear to be negatively impacted by repeat purchases due to increased disinfection cycles. Following the introduction of vaccines, the number of ultrasound procedures gradually increased. Various societies and national authorities, such as the American Institute of Ultrasound in Medicine, have developed international guidelines to address various challenges in the current scenario and ensure patient safety. Elective surgeries and ultrasound procedures are expected to be delayed as a result of the factors mentioned above, according to caregivers and hospitals. However, the market is expected to gradually rise starting in the late second half of 2021, as expected.

For more detailed information about the ultrasound probe disinfection market report, click here – https://www.databridgemarketresearch.com/reports/global-ultrasound-probe-disinfection-market